April 16, 2015 WILSON THERAPEUTICS ANNOUNCES PRESENTATION OF WTX101-201 PHASE 2 STUDY AT THE EASL 50TH INTERNATIONAL LIVER CONGRESS 2015
April 14, 2015 INDUSTRIFONDEN JOINS GLIONOVA SEK 42 MILLION ($5.7 MILLION) FINANCING CO-LED BY HEALTHCAP AND NOVO
March 26, 2015 Oversubscribed Initial Public Offering on Euronext Paris for HealthCap portfolio company Cerenis Therapeutics
March 23, 2015 Cortendo AB Announces Appointments of A. Brian Davis as Chief Financial Officer and Stephen Long as Chief Legal Officer